Skip to main content
. 2020 Jun 2;26:e921947-1–e921947-10. doi: 10.12659/MSM.921947

Figure 3.

Figure 3

(A) The optimized panel was effective in predicting the OS and PFS of low-grade glioma (P<0.001). It was useless in predicting the OS of glioblastoma but might be potentially used for predicting the PFS of glioblastoma (P=0.017). (B): ALOX5, CD44, FANCD2, NFE2L2, and SLC1A5 were increased in glioma, especially in GBM (P<0.001), while GOT1 was decreased in glioma (P<0.001).